-
Ken-ichiro Matsumoto
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
-
Aya Okajo
Department of Physical Chemistry, Showa Pharmaceutical University
-
Katsura Nagata
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences Department of Applied Bioscience, Faculty of Science, Kanagawa University
-
William G. DeGraff
Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH
-
Minako Nyui
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
-
Megumi Ueno
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
-
Ikuo Nakanishi
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences
-
Toshihiko Ozawa
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences Department of Analytical Pharmacology, Yokohama College of Pharmacy
-
James B. Mitchell
Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH
-
Murali C. Krishna
Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH
-
Haruhiko Yamamoto
Department of Applied Bioscience, Faculty of Science, Kanagawa University
-
Kazutoyo Endo
Department of Physical Chemistry, Showa Pharmaceutical University
-
Kazunori Anzai
Radiation Modifier Research Team, Heavy-Ion Radiobiology Research Group, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences